Skip to main content
Sharon Castellino, MD, Pediatric Hematology & Oncology, Atlanta, GA, Children's Healthcare of Atlanta

SharonMarieCastellinoMDMSc

Pediatric Hematology & Oncology Atlanta, GA

Pediatric Hematologic Oncology

Professor of Pediatrics, Emory University School of Medicine Director, Leukemia/Lymphoma Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta

Dr. Castellino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Castellino's full profile

Already have an account?

  • Office

    The Aflac Cancer & Blood Disorders Center ; Children's Healthcare of Atlanta; 5455 Meridian Mark Road, Suite 400
    Atlanta, GA 30342
    Phone+1 404-785-3240
    Fax+1 404-785-3600
  • Is this information wrong?

Education & Training

  • Wake Forest University
    Wake Forest UniversityMSc, Health Outcomes, 2005 - 2008
  • Duke University Hospital
    Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1995 - 1998
  • Duke University Hospital
    Duke University HospitalResidency, Pediatrics, 1994 - 1995
  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterInternship, Pediatrics, 1992 - 1994
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1992
  • Mount Holyoke College
    Mount Holyoke CollegeBA, Biochemistry, Magna Cum Laude, 1984 - 1988

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2015 - 2024
  • TN State Medical License
    TN State Medical License 1998 - 2005
  • NC State Medical License
    NC State Medical License 1994 - 2023
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Clinician Investigator Award Wake Forest School of Medicine, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Incidence and Outcomes of Lymphoid Malignancies in Adolescent and Young Adult Patients in the United States  
    Sharon Castellino, Frank G Keller, Christopher R Flowers, British Journal of Haematology
  • Occult GI Bleeding in a 1 yo Pediatric Cancer Survivor  
    Grimes K, Kratzer T, Russo K, Bourland D, Castellino SM, J Pediatr Gastroenerol Nutr., 1/1/2014
  • Hepato-Biliary Late Effects in Survivors of Childhood and Adolescent Cancer - A Report from the Children’s Oncology Group  
    Castellino SM, Muir A, Shah A, Shope S, McMullen K, Ruble K, Barber A, Davidoff A, Hudson MM, Pediatr Blood Cancer, 1/1/2010
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Outcomes and Patterns of Failure in Children/Adolescents with low risk Hodgkin Lymphoma (HL) who are FDG-PET (PET3) positive after AVPC therapy International Symposium...
    Castellino SM et. al., Childhood, Adolescent and Young Adult Hodgkin Lymphoma, 2nd International Symposium, Berlin, Germany, 1/7/2014
  • Longitudinal Evaluation of Health Status in Aging Pediatric Hodgkin Lymphoma Survivors: Report from the Childhood Cancer Survivor Study.
    Effinger K, Leisenring W, Oeffinger KC, Hudson MM, Ness KK, Marina N, Castellino SM Stovall M, Armstrong GT, Robison LL, Sainani K, Whittemore AS, International Symposium Pediatric HL, Childhood, Adolescent and Young Adult Hodgkin Lymphoma, 2nd International Symposium, Berlin, Germany, 1/7/2014
  • Intensive therapy free survival (ITFS) for early-stage Hodgkin lymphoma (cHL) including chemotherapy and radiation therapy (IFRT) for recurrence after chemotherapy al...
    Keller F, Castellino SM et al., Childhood, Adolescent and Young Adult Hodgkin Lymphoma, 2nd International Symposium, Berlin, Germany, 1/7/2014
  • Join now to see all

Lectures

  • Performance of FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric hodgkin lymphoma (HL) patients. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Proof-of-Paradigm of Cost-Effectiveness Analysis Within a Therapeutic Clinical Trial 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
  • Immune Modulation in Pediatric Lymphoma 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Join now to see all

Press Mentions

  • Expert Q&A: Addressing the Survivorship Gap in Pediatric Hodgkin Lymphoma
    Expert Q&A: Addressing the Survivorship Gap in Pediatric Hodgkin LymphomaNovember 6th, 2019
  • Woman Wants to Become a Nurse After Battling Leukemia as Teen, Overcoming Odds
    Woman Wants to Become a Nurse After Battling Leukemia as Teen, Overcoming OddsJune 5th, 2021
  • Roswell Park-Led Study: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma
    Roswell Park-Led Study: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin LymphomaJune 5th, 2022
  • Join now to see all

Professional Memberships

Hospital Affiliations